We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-7.81%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$232M
AUM Growth
-$28.6M
Cap. Flow
+$248K
Cap. Flow %
0.11%
Top 10 Hldgs %
99.94%
Holding
13
New
1
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$61M
2
VERO
Venus Concept
VERO
+$1.56M
3
DARE icon
Dare Bioscience
DARE
+$40.9K

Top Sells

Rank Stock Value
1
AVDR
Avedro, Inc Common Stock
AVDR
+$62.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 54.48%
2 Healthcare 45.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REAL icon
1
The RealReal
REAL
$1.37B
$126M 54.48%
6,704,080
– –
GKOS icon
2
Glaukos
GKOS
$8.72B
$55.2M 23.8%
1,013,364
+1,002,013
+8,828% +$61M
MGNX icon
3
MacroGenics
MGNX
$237M
$11.7M 5.04%
1,074,316
– –
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$11.4M 4.91%
25,497
– –
KALV
5
DELISTED
KalVista Pharmaceuticals
KALV
$6.92M 2.98%
388,766
– –
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
$6.58M 2.84%
1,455,904
– –
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$5.21M 2.25%
67,841
– –
STIM icon
8
Neuronetics
STIM
$123M
$4.63M 2%
1,030,689
– –
VERO
9
DELISTED
Venus Concept
VERO
$3.1M 1.33%
3,992
+1,828
+84% +$1.56M
HIND
10
Vyome Holdings
HIND
$14M
– –
0
– –
XENE icon
11
Xenon Pharmaceuticals
XENE
$6.26B
$109K 0.05%
8,293
– –
DARE icon
12
Dare Bioscience
DARE
$19.3M
$41K 0.02%
+4,197
New +$40.9K
AVDR
13
DELISTED
Avedro, Inc Common Stock
AVDR
– –
-2,745,244
Closed -$62.3M

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q4 2019 Portfolio in Review

As of Q4 2019, InterWest Venture Management held 13 positions worth $232M, down 11% from $261M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management's Q4 2019 filing shows 1 new, 2 increased and 1 closed positions. Its largest new stake was Dare Bioscience: 4,197 shares worth $41K. The largest sale was Avedro, Inc Common Stock, an estimated $62.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 54% of assets, down from 58% a quarter earlier, followed by Healthcare.

  • InterWest Venture Management's largest Q4 2019 buy was Dare Bioscience: 4,197 shares worth $41K.
  • InterWest Venture Management added most to Glaukos in Q4 2019, an estimated $61M increase.
  • InterWest Venture Management fully exited Avedro, Inc Common Stock in Q4 2019, selling an estimated $62.3M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $232M portfolio in Q4 2019.
  • InterWest Venture Management opened 1 new position and closed 1 in Q4 2019.
  • InterWest Venture Management's portfolio value fell 11% quarter-over-quarter to $232M.

Based on InterWest Venture Management's 13F filing for Q4 2019, filed 23 Jan 2020.